The free dividend tracker to help you grow your wealth. Link your brokerage accounts and MerryDiv automatically syncs your holdings and dividends.
Data last updated: Sep 28, 2026
Snapshot (as of Sep 28, 2026): AstraZeneca PLC (AZNCF) pays a $3.23 annual dividend ($0.81 quarterly), yielding 1.70% at $189.90/share. Next ex-dividend date 2026-08-07. Source: Yahoo Finance, aggregated by MerryDiv.
Dividend Yield: 1.70%
Annual Dividend: $3.23 per share
Payout Ratio: 49.1%
Ex-Dividend Date: 2026-08-07
Dividend Frequency: quarterly
Sector: Healthcare
Years of Dividend History: 18
AstraZeneca PLC dividend income comes from one of the world's largest biopharmaceutical companies, spanning oncology drugs like Tagrisso and Enhertu to cardiovascular treatments like Farxiga. The current yield sits at 1.7%, with a trailing annual dividend rate of $3.23 per share paid quarterly. The next ex-dividend date is August 7, 2026. With a beta of 0.192, AZNCF stock moves far less than the broader market, which suits income investors who prioritize low volatility over high yield.
AstraZeneca PLC pays out 49.1% of earnings as dividends, a payout ratio classified as moderate (40–60%). That level leaves meaningful earnings retained within the business, supported by a broad portfolio of prescription drugs across oncology, cardiovascular, and rare disease categories that generate recurring demand from healthcare providers worldwide. AstraZeneca PLC dividend safety faces its clearest pressure from the dividend's own history: the per-share amount has declined from $3.10 in 2014 to $2.63 in 2025, showing that earnings growth has not consistently outpaced currency and payout headwinds over the long run.
AstraZeneca PLC dividend history shows a CAGR of -0.9% per year from 2011 to 2025. Per-share payments moved from $3.00 at the start of the window to $2.63 by 2025 (the 2026 figure of $3.23 is a partial year and excluded from the CAGR calculation). The largest annual increase in the window was 2.9% in 2024, and the history contains at least one year-over-year decline exceeding 5%, confirming this is not a record of uninterrupted growth.
| Period | CAGR | From | To |
|---|---|---|---|
| 3-Year | -3.2% | $2.90 (2022) | $2.63 (2025) |
| 5-Year | -1.2% | $2.80 (2020) | $2.63 (2025) |
| 10-Year | -1.8% | $3.14 (2015) | $2.63 (2025) |
AZNCF stock fits dividend investors who want low market sensitivity and a moderate payout ratio, but are not chasing yield or growth. The yield of 1.7% is classified as low (below 2%), and it sits above the 5-year average of 1.5%, so the current entry point offers a slight yield premium relative to recent history. The payout ratio of 49.1% keeps the dividend from looking stretched. The trade-off is clear: the per-share dividend has shrunk in real terms over 14 years, and there are zero consecutive years of dividend increases. AstraZeneca PLC offers income with low price volatility, but not a growing income stream.
| Payment Date | Amount per Share |
|---|---|
| 2026-08-07 | $1.0600 |
| 2026-02-20 | $2.1700 |
| 2025-08-08 | $0.5150 |
| 2025-02-21 | $2.1150 |
| 2024-08-09 | $0.9850 |
| 2024-02-22 | $1.9710 |
| 2023-08-10 | $0.9130 |
| 2023-02-23 | $1.9610 |
| 2022-08-11 | $0.9330 |
| 2022-02-24 | $1.9680 |
| Year | Total Dividends |
|---|---|
| 2026 | $3.2300 |
| 2025 | $2.6300 |
| 2024 | $2.9560 |
| 2023 | $2.8740 |
| 2022 | $2.9010 |
Project income from AZNCF with the AZNCF dividend calculator or track your full portfolio with the dividend tracker.